Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ralph Weissleder, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ralph Weissleder and Mukesh G Harisinghani.
Connection Strength

3.940
  1. Advances in clinical MRI technology. Sci Transl Med. 2019 12 18; 11(523).
    View in: PubMed
    Score: 0.886
  2. Utility of a new bolus-injectable nanoparticle for clinical cancer staging. Neoplasia. 2007 Dec; 9(12):1160-5.
    View in: PubMed
    Score: 0.385
  3. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? AJR Am J Roentgenol. 2006 Jan; 186(1):144-8.
    View in: PubMed
    Score: 0.337
  4. A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Urology. 2005 Nov; 66(5):1066-71.
    View in: PubMed
    Score: 0.333
  5. Sensitive, noninvasive detection of lymph node metastases. PLoS Med. 2004 Dec; 1(3):e66.
    View in: PubMed
    Score: 0.314
  6. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003 Jun 19; 348(25):2491-9.
    View in: PubMed
    Score: 0.282
  7. MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. Acad Radiol. 2002 Aug; 9 Suppl 2:S312-3.
    View in: PubMed
    Score: 0.266
  8. Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients. Proc Natl Acad Sci U S A. 2015 Feb 17; 112(7):2139-44.
    View in: PubMed
    Score: 0.158
  9. Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle. Transl Oncol. 2013 Dec 01; 6(6):670-5.
    View in: PubMed
    Score: 0.146
  10. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest. 2011 Jan; 121(1):442-5.
    View in: PubMed
    Score: 0.118
  11. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. Clin Imaging. 2009 Jul-Aug; 33(4):301-5.
    View in: PubMed
    Score: 0.107
  12. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology. 2008 Apr; 71(4):708-12.
    View in: PubMed
    Score: 0.098
  13. Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers. AJR Am J Roentgenol. 2006 Dec; 187(6):W582-8.
    View in: PubMed
    Score: 0.090
  14. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1262-9.
    View in: PubMed
    Score: 0.083
  15. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations. J Comput Assist Tomogr. 2001 Sep-Oct; 25(5):770-6.
    View in: PubMed
    Score: 0.062
  16. MRI contrast agents for evaluating focal hepatic lesions. Clin Radiol. 2001 Sep; 56(9):714-25.
    View in: PubMed
    Score: 0.062
  17. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol. 1999 May; 172(5):1347-51.
    View in: PubMed
    Score: 0.053
  18. Unsupervised Medical Image Segmentation Based on the Local Center of Mass. Sci Rep. 2018 08 29; 8(1):13012.
    View in: PubMed
    Score: 0.051
  19. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex). Acad Radiol. 1998 Apr; 5 Suppl 1:S167-9, discussion S183-4.
    View in: PubMed
    Score: 0.049
  20. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. Radiology. 1997 Mar; 202(3):687-91.
    View in: PubMed
    Score: 0.046
  21. MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses. J Magn Reson Imaging. 1999 Jul; 10(1):80-3.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.